Literature DB >> 3521310

Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver.

T C Vary, J H Siegel, T Nakatani, T Sato, H Aoyama.   

Abstract

The effect of chronic sepsis on the concentration of active pyruvate dehydrogenase complex has been investigated in liver and skeletal muscle of normal, sterile inflammatory, and chronic septic (small and large abscess) animals. Hyperdynamic sepsis was induced by the intraperitoneal introduction of a rat fecal-agar pellet of known size and bacterial composition (Escherichia coli + Bacteroides fragilis). Total pyruvate dehydrogenase complex activity was not altered in either liver or skeletal muscle in any of the conditions studied. In hepatic tissue, sterile inflammation increased the proportion of active complex 2.5-fold compared with control. The same increase in the concentration of active complex was observed in animals with a small abscess. When the abscess size was increased (large abscess), the concentration of active complex was decreased relative to sterile inflammatory or small abscess septic animals. In contrast to liver, sterile inflammation did not alter the proportion of active complex in skeletal muscle. Sepsis (either small or large septic abscess) resulted in threefold decrease in the concentration of active complex relative to control or sterile inflammatory animals. Changes in the concentration of active complex did not appear to be dependent on the ATP/ADP concentration ratio or tissue pyruvate levels but were consistent with changes in the acetyl-coenzyme A-to-coenzyme A concentration ratio. The mechanism responsible for altered concentration of active complex may be mediated through changes in the activity of the pyruvate dehydrogenase kinase, secondary to alterations in the effector concentration ratios.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3521310     DOI: 10.1152/ajpendo.1986.250.6.E634

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  28 in total

Review 1.  Dysoxia and lactate.

Authors:  T Duke
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

2.  Mitochondrial dysfunction and resuscitation in sepsis.

Authors:  Albert J Ruggieri; Richard J Levy; Clifford S Deutschman
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

3.  Effects of recombinant monokines on hepatic pyruvate dehydrogenase, pyruvate dehydrogenase kinase, lipogenesis de novo and plasma triacylglycerols. Abolition by prior fasting.

Authors:  M Blackham; D Cesar; O J Park; T C Vary; K Wu; S Kaempfer; C H Shackleton; M K Hellerstein
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

Review 4.  Lactic acidosis in sepsis: a commentary.

Authors:  G Gutierrez; M E Wulf
Journal:  Intensive Care Med       Date:  1996-01       Impact factor: 17.440

5.  Potential non-hypoxic/ischemic causes of increased cerebral interstitial fluid lactate/pyruvate ratio: a review of available literature.

Authors:  Daniel B Larach; W Andrew Kofke; Peter Le Roux
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

Review 6.  Tissue hypoxia. How to detect, how to correct, how to prevent?

Authors:  C Richard
Journal:  Intensive Care Med       Date:  1996-11       Impact factor: 17.440

Review 7.  The pulmonary physician in critical care * 2: oxygen delivery and consumption in the critically ill.

Authors:  R M Leach; D F Treacher
Journal:  Thorax       Date:  2002-02       Impact factor: 9.139

8.  Do not forget to give thiamine to your septic shock patient!

Authors:  Jihad Mallat; Malcolm Lemyze; Didier Thevenin
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

9.  Gastric tonometry in septic shock.

Authors:  M Hatherill; S M Tibby; R Evans; I A Murdoch
Journal:  Arch Dis Child       Date:  1998-02       Impact factor: 3.791

10.  Acute effects of endotoxin (lipopolysaccharide) on tissue lipid metabolism in the lactating rat. The role of delivery of intestinal glucose.

Authors:  F J López-Soriano; D H Williamson
Journal:  Mol Cell Biochem       Date:  1994-12-21       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.